Back
CRISPR Therapeutics AG Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
CRSP
CRISPR Therapeutics AG
Last Price:
51.28
Seasonality Move:
12.85%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 49.64 | Buy |
| 50-day SMA: | 48.1 | Buy |
| 200-day SMA: | 56.72 | Sell |
| 8-day EMA: | 49.55 | Buy |
| 20-day EMA: | 49.11 | Buy |
| 50-day EMA: | 48.88 | Buy |
| 200-day EMA: | 53.16 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 57.03 | Buy |
| Chaikin Money Flow: | 224076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.25 - 51.41) | Buy |
| Bollinger Bands (100): | (45.51 - 53.53) | Buy |
CRISPR Therapeutics AG Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 51.17 while CRSP 8-day simple moving average is 48.77, which is a Buy signal.
- The stock price of CRSP is 51.17 while CRISPR Therapeutics AG 20-day SMA is 49.64, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 48.10 while CRSP share price is 51.17, making it a Buy technically.
- CRSP stock price is 51.17 and CRISPR Therapeutics AG 200-day simple moving average is 56.72, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
59
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Buy
The current CRISPR Therapeutics AG [CRSP] share price is $51.17. The Score for CRSP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.37B
Price in USD:
51.17
Share Volume:
757.59K
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
43.42
Buy
59
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 51.17 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 51.17 while CRSP 8-day exponential moving average is 49.55, which is a Buy signal.
- The stock price of CRSP is 51.17 while CRISPR Therapeutics AG 20-day EMA is 49.11, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 48.88 while CRSP share price is 51.17, making it a Buy technically.
- CRSP stock price is 51.17 and CRISPR Therapeutics AG 200-day simple moving average is 53.16, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting CRISPR Therapeutics AG is a Buy
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 57.03, which suggest CRISPR Therapeutics AG is overbought
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (47.25 - 51.41), which suggest CRISPR Therapeutics AG is a Buy
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (45.51 - 53.53), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.